发明申请
US20050020660A1 Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
失效
奎宁环衍生物的制备方法及其作为m2和/或m3毒蕈碱受体抑制剂的用途
- 专利标题： Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
- 专利标题（中）： 奎宁环衍生物的制备方法及其作为m2和/或m3毒蕈碱受体抑制剂的用途
-
申请号： US10490436申请日： 2002-09-23
-
公开(公告)号： US20050020660A1公开(公告)日： 2005-01-27
- 发明人: Michel Guyaux , Chimmanamada Dinesh , Charles Mioskowski , Luc Quere , Jean-Philippe Starck , Patrice Talaga , Alain Wagner , Mateo Zanda
- 申请人： Michel Guyaux , Chimmanamada Dinesh , Charles Mioskowski , Luc Quere , Jean-Philippe Starck , Patrice Talaga , Alain Wagner , Mateo Zanda
- 优先权： EP01124727.7 20011017
- 国际申请： PCT/EP02/10644 WO 20020923
- 主分类号： A61K31/439
- IPC分类号： A61K31/439 ; A61K31/444 ; A61P1/00 ; A61P9/00 ; A61P11/00 ; A61P13/02 ; A61P25/20 ; A61P25/28 ; C07D453/02 ; C07F7/10 ; C07D487/02 ; A61K31/407
摘要：
The invention concerns quinuclidine derivatives of formula I or II wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention_show high affinities for m3 and/or m2 muscarinic receptors and are particularly suited for treating urinary incontinence.
公开/授权文献
信息查询
IPC分类:
